Trailing-twelve-month (TTM) revenue is $5.25 Billion with a year-over-year growth of +6.52%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,291,257,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $1,319,278,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $1,296,297,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $1,343,438,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $5,250,270,000 |
Current P/S: $5,956,475,980 market capitalization ÷ $5,250,270,000 TTM revenue = 1.13x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.34B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:32.856Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-30 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Banking Capital Markets And Insurance | N/A | $1.0B | N/A | N/A | N/A | N/A |
| Consumer and Healthcare | $1.3B | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $1.0B | $1.0B | $1.1B | $980M | $683M | $730M |
| Asia Other Than India | $462M | $537M | $551M | $643M |
$5.25B
$5.25 Billion
+6.52%
vs. $4.93B a year ago (TTM)
+6.57%
5 Year compound annual growth rate
1 Year
+6.52%
3 Year
+6.00%
5 Year
+6.57%
10 Year
+7.68%
15 Year
+9.26%
20 Year
+12.38%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $5.08B | +$312.74M | +6.56% |
| 2024 | $4.77B | +$290.25M | +6.48% |
| 2023 | $4.48B | +$105.72M | +2.42% |
| 2022 | $4.37B | +$348.96M | +8.68% |
| 2021 | $4.02B | +$312.83M | +8.43% |
| 2020 |
TTM Growth
+6.52%
3-Year CAGR
+6.00%
5-Year CAGR
+6.57%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:32.856Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| N/A |
| Consumer And Healthcare | N/A | $1.5B | $1.6B | $1.6B | $1.7B | $1.7B |
|---|
| Financial Services | $1.1B | N/A | N/A | N/A | N/A | N/A |
|---|
| High Tech and Manufacturing | $1.4B | N/A | N/A | N/A | N/A | N/A |
|---|
| High Tech Manufacturing And Services | N/A | $1.5B | N/A | N/A | N/A | N/A |
|---|
| Other | -$23M | N/A | N/A | N/A | N/A | N/A |
|---|
| $788M |
| Europe | $389M | $452M | $471M | $533M | $622M | $578M |
|---|
| INDIA | $1.9B | $2.0B | $2.3B | $2.3B | $2.8B | $3.0B |
|---|
| $3.71B |
| +$188.83M |
| +5.36% |
| 2019 | $3.52B | +$519.75M | +17.32% |
| 2018 | $3.00B | +$263.86M | +9.64% |
| 2017 | $2.74B | +$166.17M | +6.46% |
| 2016 | $2.57B | +$109.71M | +4.46% |
